Studies have demonstrated that curcumin enhances the activity of PD-1/PD-L1 antibodies in murine colon cancer (MC38 and CT26) and liver cancer (Hep3B) cells by effectively preventing immune evasion [370, 371]. Here, CD274 is linked to malignant colon neoplasm.